The synthesis method of the Cagrilintide comprises the third step of preparing 200mL of cracking reagent, adding the full-protection peptide under an ice bath condition, returning to room temperature after 0.5h, continuing to react for 2h, adding anhydrous ether for precipitation after the reaction is finished, performing centrifugal precipitation for multiple times, adding 300mL of ether each time, and drying to obtain the Cagrilintide product
Journal of Ethnopharmacology, 137 (3), 1143-1148
Three sets of 0.02 mg/mL glutathione solutions were added to L-leucine, L-threonine and L-valine for SEIRA determination, and the results showed that the tolerance limit was 0.25 mg/mL for these three amino acids
Many clients notice increased energy and mental clarity within 2472 hours of their first injection
The primary therapeutic application of Cagrilintide is focused on weight management and treating obesity-related conditions such as type 2 diabetes